Related Experiment Video
Updated: Dec 5, 2025

07:30
Rapid Nanoprobe Signal Enhancement by In Situ Gold Nanoparticle Synthesis
Published on: March 7, 2018
7.9K
Gold nanoparticles to enhance ophthalmic imaging
Fang Chen1, Peng Si, Adam de la Zerda
1Mary M. and Sash A. Spencer Center for Vision Research, Byers Eye Institute, Department of Ophthalmology, Stanford University, CA 94305, USA. fachen@stanford.edu.
Biomaterials Science
|October 15, 2020
Summary
Gold nanoparticles show promise for ophthalmic molecular imaging, enhancing early eye disease detection. This review explores their use in optical coherence tomography and photoacoustic imaging for improved diagnostics.
Area of Science:
- Nanotechnology
- Ophthalmology
- Biomedical Imaging
Background:
- Gold nanoparticles (AuNPs) are increasingly used in cancer theranostics.
- Ophthalmic applications of AuNPs are emerging, but a need exists for advanced diagnostic tools.
- Current ophthalmic imaging lacks sensitivity for early disease detection before structural changes.
Purpose of the Study:
- To review current ophthalmic imaging techniques.
- To identify promising imaging modalities for gold nanoparticle integration.
- To detail the development of gold nanoparticles as contrast agents for specific ophthalmic imaging.
Main Methods:
- Literature review of ophthalmic imaging techniques.
- Analysis of gold nanoparticle applications in other medical fields.
- Focused review on gold nanoparticles for optical coherence tomography (OCT) and photoacoustic imaging (PAI).
Main Results:
- Optical coherence tomography (OCT) and photoacoustic imaging (PAI) are identified as key modalities for AuNP-based ophthalmic molecular imaging.
- Gold nanoparticles show potential as contrast agents for enhanced OCT and PAI.
- Recent advancements in AuNP development for these imaging techniques are discussed.
Conclusions:
- Gold nanoparticles offer significant potential for advancing ophthalmic molecular imaging.
- Integration of AuNPs with OCT and PAI could revolutionize early eye disease diagnosis.
- Further research into AuNP-based contrast agents is crucial for clinical translation.

